Previous works have shown that elevated UBE2S expression promoted the proliferation, invasion, metastasis, and G1/S phase transition of cell cycle in HCC through interacting with TRIM28 [4], and decreased UBE2S expression recovered drug sensitivity in GBM via suppressing NHEJ-mediated DSB repair [9]. This evidence concerns the gene UBE2S and hepatocellular carcinoma.